Gliclazid-Mepha 60 retard

Gliclazid-Mepha 60 retard is a medicine authorised by Swissmedic under authorisation number 65571. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 February 2015 and the authorisation is valid without a time limit. ATC code A10BB09 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 65571
  • ATC A10BB09
  • Synthetic medicines
Authorisation data
Authorisation number65571
NameGliclazid-Mepha 60 retard
Full nameGliclazid-Mepha 60 retard, Depotabs
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA10BB09
First authorisation26 February 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Gliclazid-Mepha 60 retard, DepotabsB26 February 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)A10BB0907.06.2.B
290Tablette(n)A10BB0907.06.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Gliclazid-Mepha 60 retard authorised in Switzerland?

Yes. Gliclazid-Mepha 60 retard is authorised by Swissmedic under authorisation number 65571, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Gliclazid-Mepha 60 retard have?

Gliclazid-Mepha 60 retard is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Gliclazid-Mepha 60 retard?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com